Multi-variate analysis predicts clinical outcome 30 days after middle cerebral artery infarction

Acta Neurologica Scandinavica

Volumn 102, Issue 1, 2000, Pages 11-17

  Lemesle, M ^a   Walker, P ^a   Guy, F ^a   D'Athis, P ^a   Billiar, T ^a   Giroud, M ^a   Demougeot, C ^b   Lalande, A ^a   Baudouin, N ^a   Martin, D ^a   Brunotte, F ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Prognosis; Spectroscopy; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CORRELATION FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; SEX DIFFERENCE;

ADULT; AGED; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034051304     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.102001011.x     Document Type: Article

References (26)

1. 1. GIDEON P, SPERLING B, ARLIEN-SOBORG P, OLSON TS, HENRIKSEN O. Long term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke 1994;25:967-73.
2. 2. GRAHAM GD, BLAMIRE AM, ROTHMAN DL et al. Early temporal variation of cerebral metabolites after human stroke: a proton magnetic resonance spectroscopy study. Stroke 1993;24:1891-6.
3. 3. GRAHAM GD, KALVACH P, BLAMIRE AM, BRAS LM, FAYAD PB, PRICHARD JW. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 1995;26:225-9.
4. 4. Classification of cerebrovascular disease. III. Special report from the National Institute of Neurological Disorders and Stroke. Stroke 1990;21:637-76.
5. 5. ORGOGOZO JM, DARTIGUES JF. Methodology of clinical trials in acute cerebral ischemia: survival, functional and neurological outcome measures. Cerebrovasc Dis 1991;(Suppl. 1):100-11.
6. 6. DAMASIO H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol 1983;40:132-42.
7. 7. VON KUMMER R. Early CT diagnosis of hemispheric brain infarction. In: VON KUMMER R, BOZZAO L, MANEFFE C, eds. Berlin/New York: Springer-Verlag, 1995.
8. 8. BRANT-ZAWADSKI M, KUCHARCZYK W. Vascular disease: ischemia. In: BRANT-ZAWADSKI M, NORMAN D, eds. Magnetic Resonance Imaging of the cerebral nervous system. New York: Raven Press, 1987:221-34.
9. 9. FRAHM J, BRUHN H, GYNGELL ML, MERBOLDT KD, HANICKE W, SANTER R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Mag Reson Med 1989;9:79-93.
10. 10. FENSTERMACHER MJ, NARAYANA NA. Serial proton MRS of ischemic brain injury in humans. Invest Radiol 1990;25:1034-9.
11. 11. HOUKIN K, KAMADA K, KAMIYAMA H, IWASAKI Y, ABE H, KASHIWABA T. Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction. Stroke 1993;24:1316-21.
12. 12. SAUNDERS DE, HOWE FA, VAN DEN BOOGART A, MAC-LEAN MS, GRIFFITHS JR, BROWN MM. Continuing ischaemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 1995;26:1007-13.
13. 13. GRAHAM GD, BLAMIRE AM, HOWESEMAN AM et al. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 1992;23:333-40.
14. 14. URENJAK J, WILLIAMS SR, GADIAN DG, NOBLE M. Specific expression of N-acetyl-aspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. N. Neurochem 1992;59:55-61.
15. 15. GIDEON P, HENRIKSEN O, SPERLING B et al. Early time course of N-acetyl-aspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: a proton magnetic resonance, spectroscopy study. Stroke 1992;23:1566-72.
16. 16. IGARASCHI H, NAKADA T, KWEE IL, KATAYAMA Y, TERASHI A. Serial measurement of 1HMRS spectroscopic images in permanent focal ischemia. Cerebrovasc Dis 1996;6(Suppl. 2):80.
17. 17. LUYTEN PR, MARIEN AJH, HEINDEL W et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-9.
18. 18. BLAMIRE AM, GRAHAM GD, ROTHMAN DL, PRICHARD JW. Proton spectroscopy of human stroke: assessment of transverse relaxation times and partial volume effects in single volume STEAM MRS. Magn Reson Imaging 1994;12:1227-35.
19. 19. FELBER SR, AICHNER FT, SAUTER R, GERSTENBRAND F. Combined magnetic resonance imaging and proton magnetic resonance spectroscopy of patients with acute stroke. Stroke 1992;23:1106-10.
20. 20. GARCIA JH, KIMIJYO Y. Cerebral infarction: evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J Neuropathol Exp Neurol 1974;33:408-21.
21. 21. BIRKEN DL, OLDENDORF WH. N-acetyl-aspartate acid: a literature review of a compound prominent in 1H-NMR Spectroscopic studies of the brain. Neurosci Biobehav Rev 1989;13:23-31.
22. 22. LEVINE SR, HELPERN JA, WELCH KMA et al. Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. Radiology 1992;185:537-44.
23. 23. SAUNDERS DE, HOWE FA, PEREIRA A, BROWN MM, GRIFFITHS JR. The use of magnetic resonance spectroscopy in the prediction of clinical outcome in MCA infarct patients. Cerebrovasc Dis 1996;6(Suppl. 2):81.
24. 24. FEDERICO F, LUCIVERO V, SIMONE IL, MEZZAPESA DM. Proton MR spectroscopy in acute, subacute, and chronic cerebral infarctions. Arch Neurol 1998;55:489-94.
25. 25. WARDLAW JM, MARSHALL I, WILD J, DENNIS MS, CANNON J, LEWIS SC. Studies of acute ischaemic stroke with proton magnetic resonance spectroscopy. Relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow and clinical outcome. Stroke 1998;29:1618-24.
26. 26. FIORELLI M, ALPEROVITCH A, ARGENTINO C et al. Prediction of long-term outcome in the early hours following acute ischaemic stroke. Arch Neurol 1995;52:250-5.